RAGONESE, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 17.586
EU - Europa 11.266
AS - Asia 8.560
SA - Sud America 1.253
AF - Africa 286
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 22
Totale 39.028
Nazione #
US - Stati Uniti d'America 17.317
SG - Singapore 2.985
RU - Federazione Russa 2.860
IT - Italia 2.280
CN - Cina 2.267
FI - Finlandia 1.353
DE - Germania 1.152
BR - Brasile 989
UA - Ucraina 896
HK - Hong Kong 889
VN - Vietnam 824
PL - Polonia 578
GB - Regno Unito 510
FR - Francia 435
IE - Irlanda 401
JP - Giappone 335
IN - India 220
KR - Corea 220
SE - Svezia 191
BD - Bangladesh 144
CA - Canada 129
BE - Belgio 128
IQ - Iraq 105
AR - Argentina 102
NL - Olanda 102
IR - Iran 101
RO - Romania 99
TR - Turchia 94
MX - Messico 76
AT - Austria 72
CI - Costa d'Avorio 55
ES - Italia 51
MA - Marocco 47
UZ - Uzbekistan 47
EG - Egitto 45
AU - Australia 44
PK - Pakistan 43
ZA - Sudafrica 42
ID - Indonesia 38
VE - Venezuela 34
EC - Ecuador 30
SA - Arabia Saudita 30
KE - Kenya 29
MY - Malesia 27
CZ - Repubblica Ceca 26
BG - Bulgaria 24
CL - Cile 22
GR - Grecia 22
JO - Giordania 22
PH - Filippine 22
CO - Colombia 20
PY - Paraguay 19
CH - Svizzera 18
DZ - Algeria 18
KZ - Kazakistan 18
AE - Emirati Arabi Uniti 17
LT - Lituania 17
EU - Europa 16
NP - Nepal 16
TN - Tunisia 15
IL - Israele 14
HN - Honduras 13
PE - Perù 13
AZ - Azerbaigian 12
UY - Uruguay 12
CR - Costa Rica 11
JM - Giamaica 11
LB - Libano 10
NZ - Nuova Zelanda 9
BO - Bolivia 8
ET - Etiopia 8
GE - Georgia 8
TW - Taiwan 8
NG - Nigeria 7
PA - Panama 7
AL - Albania 6
KG - Kirghizistan 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
AM - Armenia 4
AO - Angola 4
MK - Macedonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CY - Cipro 3
DK - Danimarca 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
NI - Nicaragua 3
Totale 38.986
Città #
Ashburn 2.200
Singapore 1.971
Fairfield 1.569
San Jose 1.029
Chandler 988
Woodbridge 894
Houston 878
Hong Kong 833
Ann Arbor 742
Wilmington 665
Seattle 613
Moscow 513
Cambridge 493
Zgierz 493
Jacksonville 482
Palermo 463
Dublin 391
Beijing 351
Des Moines 344
Secaucus 341
Medford 324
Tokyo 321
Dallas 312
Los Angeles 312
Ho Chi Minh City 307
Santa Clara 297
Frankfurt am Main 253
Nanjing 244
New York 233
Lauterbourg 221
Princeton 206
Hefei 200
Boardman 188
Council Bluffs 179
Hanoi 170
Altamura 169
The Dalles 154
Milan 131
Tulsa 127
Lawrence 125
Dearborn 120
Brussels 114
Buffalo 114
Helsinki 109
San Diego 94
São Paulo 94
Shenyang 86
Chicago 79
Changsha 76
London 76
Seoul 76
Jinan 72
Tianjin 69
Nanchang 66
Ludwigshafen am Rhein 63
Hebei 62
Rome 60
Abidjan 54
Jiaxing 51
Orem 51
Warsaw 50
Da Nang 45
Amsterdam 44
Toronto 43
Atlanta 42
Baghdad 42
Nuremberg 42
Venice 42
Zhengzhou 41
Haiphong 39
Seongnam 39
Ningbo 38
Tehran 38
Hangzhou 37
Phoenix 37
Saint Petersburg 37
Columbus 36
Kumar 35
Verona 35
Chennai 34
Guangzhou 33
Tashkent 33
Vienna 32
Montreal 30
Stockholm 30
Johannesburg 29
Rio de Janeiro 29
Brooklyn 28
Istanbul 28
Munich 28
Naples 28
Denver 27
Sydney 26
Washington 26
Durham 24
Norwalk 24
Belo Horizonte 23
Biên Hòa 23
Dhaka 23
Düsseldorf 23
Totale 23.655
Nome #
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study. 1.037
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 361
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 335
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis 300
INCIDENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN SICILY: A POPULATION BASED STUDY. 289
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 283
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 266
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 260
Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome 258
A population-based survey of cognitive performance in a Sicilian elderly community. 257
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 255
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 250
Age at menopause predicts age at onset of Parkinson's disease. 248
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 248
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 245
Klotho and vitamin D in multiple sclerosis: an Italian study 244
Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura 242
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 240
Fumo, caffè e rischio di Sclerosi Multipla: uno studio caso-controllo 239
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control study. 237
Dropped head as an unusual presenting sign of myasthenia gravis 236
The relapse rate of multiple sclerosis changes during pregnancy: a cohort study 234
Association of CYP2R1 rs10766197 with MS risk and disease progression 233
Risk of Parkinson disease in women: effect of reproductive characteristics 232
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 232
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 231
Blood Lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients 230
Frequency and Determinants for Hemorrhagic Transformation of Cerebral Infarction 227
A CASE-CONTROL STUDY ON THE ASSOCIATION BETWEEN DIABETES AND PD 225
Search for genetic factors associated with susceptibility to multiple sclerosis. 224
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 224
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 218
LEVETIRACETAM IN THE TREATMENT OF VASCULAR CHOREA: A CASE REPORT 217
Multiple sclerosis survival: a population-based study in Sicily. 217
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 217
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex 216
Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B(12) in the acute phase of atherothrombotic stroke. 215
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies 214
Parkinson's Disease and Cancer 213
BODY MASS INDEX DOES NOT CHANGE BEFORE PARKINSON'S DISEASE ONSET. 211
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 211
Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects. 205
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 205
Determinants of depressive symptoms among spouse caregivers of patients with Parkinson's disease 203
Diabetes preceding Parkinson's disease onset. A case-control study 202
Analisi dei Polimorfismi di Citochine Th2 nella Sclerosi Multipla. 201
A case control study to evaluate the relationship between cigarette smoking or coffee consumption and multiple sclerosis 200
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 199
MRI abnormalities following repeated and incoming seizures 198
Age at onset of parkinson's disease in women is associated with age at menopause. 197
Food of the Gods for the Treatment of Multiple Sclerosis Related Fatigue? 197
Dropped head as an unusual presenting sign of myasthenia gravis 196
FREQUENCY AND DETERMINANTS FOR HEMORRHAGIC TRANSFORMATION OF CEREBRAL INFARCTION 196
Determinants of depressive symptoms among spouse caregivers of patients with Parkinson’s disease 195
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a screening questionnaire. 195
Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy 195
Efficacy of 12 weeks of proprioceptive training in patients with multiple sclerosis 195
Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study 189
A post-marketing comparison study on disability modification in progressive multiple sclerosis after interferon beta-1b or mitoxantrone therapy 188
Depression and associated factors among spouse-caregivers of patient with Parkinson’s disease 187
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. 187
BODY MASS INDEX AND PARKINSON'S DISEASE: A CASE-CONTROL STUDY 186
Autosomal dominant hereditary spastic paraplegia: report of a large italian family with R581X spastin mutation. 186
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 186
Effects of transcranial random noise stimulation combined with Graded Repetitive Arm Supplementary Program (GRASP) on motor rehabilitation of the upper limb in sub-acute ischemic stroke patients: a randomized pilot study. 186
A SPG4 GENE MUTATION CAUSES AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA IN AN ITALIAN FAMILY 184
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients 184
Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early onset Parkinson’s disease 183
Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status 182
remarkably increasing incidence of multiple sclerosis. A follow-up study in Caltanissetta, Sicily 181
Remarkably increasing incidence of Multiple Sclerosis. A follow-up study in calatanissetta, Sicily 181
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 181
HIGH PREVALENCE AND FAST RISING INCIDENCE OF MULTIPLE SCLEROSIS IN CALTANISSETTA, SICILY, SOUTHERN ITALY. 180
Frequency and determinants for hemorragic transformation of cerebral infarction 180
Dentatorubral-pallidoluysian atrophy: Haplotype of Asian origin in 2 Italian families. 180
Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach 178
Tumor diagnosis preceding Parkinson's disease: a case-control study. 177
A Door-to-Door population based survey on cognitive performance In Bagheria, Sicily. 177
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 176
Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke : Posterior ischemic stroke and hemorrhagic transformation. 176
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 174
Hypoxanthine and purine compounds in plasma from patients with multiple sclerosis and psoriasis 173
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 173
Further evidence of genetic heterogeneity in familial essential tremor. 172
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 172
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 172
CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study 172
An unexpected association between intracranial hypotension and split cord malformation 171
Frequency and determinants for hemorrhagic transformation of cerebral infarction. 171
Leprosy: report of a case with severe peripheral neuropathy. 170
Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors 170
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients 169
A population-based survey on cognitive performance in Sicily. Cognitive impairment is modified by fertile life characteristics. 169
Blood lipid, homocysteine, uric acid and vitamins in clinically stable Multiple Sclerosis patients 169
Search for genetic factors associated with susceptibility to multiple sclerosis. 168
Frequency and determinants for hemorrhagic trasformation of cerebral infarction 167
Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with natalizumab therapy 167
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 167
A new road to improve vitamin D and balance through Taopatch® and proprioceptive protocol in Multiple Sclerosis patients 167
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 166
Totale 21.544
Categoria #
all - tutte 133.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021526 0 0 0 0 0 0 0 0 0 0 251 275
2021/20222.240 107 538 49 83 60 68 108 118 239 287 114 469
2022/20233.532 359 512 76 300 432 542 329 293 357 57 195 80
2023/20241.835 93 239 191 153 175 296 150 129 37 60 39 273
2024/20254.438 167 378 288 391 189 132 291 234 312 470 598 988
2025/202615.633 1.222 799 956 1.449 1.409 2.391 1.928 1.682 1.203 2.053 541 0
Totale 39.947